Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conferenceseries Ltd: World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Previous Speakers

Stef Stienstra

Stef Stienstra

Armed Forces of Netherlands Netherlands

Paul Kadetz

Paul Kadetz

Drew University USA

Lia Monica Junie

Lia Monica Junie

University of Medicine and Pharmacy Romania

Christine I Wooddell

Christine I Wooddell

Arrowhead Pharmaceuticals USA

Saungi McCalla

Saungi McCalla

White Plains Hospital USA

Shirley Gutkowski

Shirley Gutkowski

Primal Air LLC USA

Ibrahim Zeid

Ibrahim Zeid

Hammoud Hospital University Lebanon

Dhruv K. Mamtora

Dhruv K. Mamtora

S. L. Raheja Hospital India

Infection Control 2018

About Conference


After the overwhelming success of the conference in 2017, We, Conference Series, are glad to welcome all the attendees, presenters and exhibitors from all over the world to Vancouver, Canada on June 25-26, 2018 for “3rd International Conference on Infection Control”. We invite you all to share your knowledge and expertise on theme of To Safeguard Public Health” with the fellow attendees and presenters.

Conference Series Ltd organizes a conference series  of 1000+ Global Events inclusive of 1000+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

The Infection Control conference hosting presentations from editors of eminent refereed journals, renowned and active investigators and decision makers in the field of infectious diseases, microbiology, immunology, infection control and prevention. Infection control 2018 Organizing Committee also invites young investigators at each and every career stage to submit abstracts reporting their latest scientific researches in oral and poster sessions.

Infection control is required to prevent the transmission of communicable diseases in all health care settings. Infection control demands a basic understanding of the epidemiology of diseases; risk factors that increase patient susceptibility to infection; and the practices, procedures and treatments that may result in infections. the risk of acquiring a healthcare-associated infection is related to the mode of transmission of the infectious agent (e.g. CRE, CDI, MRSA, SSI, etc.) and the type of patient-care activity or procedure being performed and the underlying patient’s host defences.

When we look at the worldwide deaths due to Infectious Diseases the conference get significance on some diseases like Tetanus (500,000), measles (1 million), Malaria (2.1million), hepatitis b (1.1million), diarrhoea (3.1 million), tuberculosis (3.1 million), HIV/AIDS (1 million) and respiratory Infections (4.4 million).

Who should attend?

  • Microbiologists
  • Bacteriologists
  • Virologists
  • Parasitologists
  • Mycologists
  • Pathologists
  • Pharmacists
  • Epidemiologists
  • Health Care Professionals
  • Infectious Diseases Specialists
  • Infection Prevention and Infection Control Specialists

Why to attend?

With members from all over the world concentrated on learning about global trends on emerging infectious diseases and it promotes in therapeutic and diagnostic market, this is your finest chance to reach the largest accumulation of participants from the Infectious diseases community. This particular conference Infection Control conduct presentations, distributes information, conducts meetings with current and prospective scientists, make a splash with new drug developments, and receive name recollection at this 2 days event. World distinguished speakers, the most recent therapeutic and diagnostic techniques, developments of Novel technologies and therapeutic measures for infectious diseases prevention and treatment are the authentication marks of this conference.

Targeted Audience

  • Directors, Board Members, Presidents, Vice Presidents, Deans and Head of the Departments
  • Infectious Diseases Researchers, Scientists, Faculties, Students
  • Infectious Diseases Associations and Societies
  • Medical Colleges
  • Pharmaceutical Companies and Industries
  • Medical Devices Manufacturing Companies
  • Drug Manufacturing Companies and Industries
  • Laboratory Technicians and Diagnostic Companies
  • Business Entrepreneurs and Industrialists
  • Training Institutes
  • Software Developing Companies
  • Data Management Companies

For Scientific Sessions please go through the link:

http://infectioncontrol.conferenceseries.com/call-for-abstracts.php

For Abstract Submission please go through the link:

http://infectioncontrol.conferenceseries.com/abstract-submission.php

Sessions/Tracks

Track 01: Infection Treatment and Control

Infection prevention and control is required to prevent the transmission of Contagious Diseases in all health care systems. These diseases are usually caused by bacteria or viruses and can be spread by human to human contact, animal to human contact, human contact with an infected surface, airborne transmission through small droplets of infectious agents suspended in the air and finally, by such common vehicles as water or food. Infection Control and Prevention demands a basic understanding of the epidemiology of diseases, risk factors that increase patient susceptibility to infection, and the practices, procedures and treatments that may result in infections. Recent techniques have proved that there is no disease that cannot be treated.

Related Conferences

Infectious Conferences | infections Meetings | Emerging diseases 2018 | Infectious diseases conference

4th Annual Congress on Infectious Diseases September 17-18, 2018 San Diego, USA, 3rd Annual Congress on Rare Diseases and Orphan Drugs October 30-November 1, 2017 San Antonio, Texas, USA, 3rd International Conference on Flu and Emerging Infectious Diseases November 06-07, 2017 Las Vegas, Nevada, USA, 13th World Congress on Infection Prevention and Control Dec 14-15, 2017 Rome, Italy, 5th International congress on Infectious Diseases March 1-2, 2018 Berlin, Germany, 7th International Conference on Bacteriology and Infectious Diseases May 21-22, 2018 Osaka, Japan, 6th International Congress on Bacteriology and Infectious Diseases May 21-22, 2018 New York, USA, 4th World Congress on Rare Diseases and Orphan Drugs June 11-12, 2018 Dublin, Ireland, 4th International Conference on Influenza and Zoonotic Diseases July 2-3 2018 Vienna, Austria, 4th International conference on Flu & Emerging Infectious Diseases November 16-17, 2018 San Antonio, USA.

Track 02: Emerging infectious diseases

An Infectious disease whose occurrence has increased in the past years or a cause to increase is termed as emerging. These diseases include new infections, previously unrecognized infections and old infections reappearing due to antimicrobial resistance, public health issues and unhygienic conditions. Human infectious agents emerge and appear assignable to interaction of multiple advanced factors between the host and pathogen every driven by the requirement to secure the success of the species in dynamical environments. Adaptation by one partner to take advantage of new environments can typically stimulate the opposite to switch its features to require advantage of the change.

Related Conferences

Infectious Conferences | infections Meetings | Emerging diseases 2018 | Infectious diseases conference

9th International Conference on Emerging Infectious Diseases August 27-28, 2018 Zurich, Switzerland 3rd Annual Congress on Rare Diseases and Orphan Drugs October 30-November 1, 2017 San Antonio, Texas, USA, 4th Annual Congress on Infectious Diseases September 17-18, 2018 San Diego, USA,  5th International congress on Infectious Diseases March 1-2, 2018 Berlin, Germany, 6th International Congress on Bacteriology and Infectious Diseases May 21-22, 2018 New York, USA, 4th International Conference on Influenza and Zoonotic Diseases July 2-3 2018 Vienna, Austria, 8th Asia Pacific STD and Infectious Diseases Congress, August 22-23, 2018 Tokyo, Japan, 13th World Congress on Infection Prevention and Control  Dec 14-15, 2017 Rome, Italy, 4th World Congress on Rare Diseases and Orphan Drugs June 11-12, 2018 Dublin, Ireland, 11th World Congress on Infectious Diseases and Therapy, July 23-25, 2018 Melbourne, Australia, 10th Euro-Global Conference on Infectious Diseases September 27-29, 2018 Rome, Italy, 6th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs October 29-30, 2018 Valencia, Spain

Track 03: Infection Novel Therapies

Infectious Diseases and Therapy is of high-quality preclinical, observational, clinical, real-world and health outcomes research around the discovery, development and use of infectious disease therapies and interventions, including vaccines and devices. Studies relating to diagnostic products and diagnosis, public health, quality of life, pharmacoeconomics and patient care, management and education are also encouraged.  The Global Infection Control in Cancer Therapy Market is poised to grow at a CAGR of around 15.5% over the forecast period 2015 to 2025.

Related Conferences

Infectious Conferences | infections Meetings | Emerging diseases 2018 | Infectious diseases conference

6th International Congress on Bacteriology and Infectious Diseases May 21-22, 2018 New York, USA, 3rd Annual Congress on Rare Diseases and Orphan Drugs , October 30-November 1, 2017 San Antonio, Texas, USA, 7th International Conference on Bacteriology and Infectious Diseases May 21-22, 2018 Osaka, Japan, 4th International Conference on Influenza and Zoonotic Diseases July 2-3 2018 Vienna, Austria, 9th International Conference on Emerging Infectious Diseases August 27-28, 2018 Zurich, Switzerland, 4th Annual Congress on Infectious Diseases September 17-18, 2018 San Diego, USA, 6th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs October 29-30, 2018 Valencia, Spain, 13th World Congress on Infection Prevention and Control Dec 14-15, 2017 Rome, Italy, 11th World Congress on Infectious Diseases and Therapy, July 23-25, 2018 Melbourne, Australia, 12th Annual Meet on Bacteriology & Applied Microbiology September 17-18, 2018 Singapore, 10thEuro-Global Conference on Infectious Diseases September 27-29, 2018 Rome, Italy, 5th International congress on Infectious Diseases March 1-2, 2018 Berlin, Germany, 4th World Congress on Rare Diseases and Orphan Drugs June 11-12, 2018 Dublin, Ireland, 8th Asia Pacific STD and Infectious Diseases Congress, August 22-23, 2018 Tokyo, Japan

Track 04: Treatment & Diagnosis

Bacterial Infections are treated by giving antibiotics to the patients. Medical diagnosis is the process of determining which disease or state explains a person's symptoms and signs. Laboratory tests may identify organisms directly for e.g., visually, using a microscope growing the organism in culture or indirectly for e.g., identifying antibodies to the organism. General types of tests include microscopy, culture and immunologic tests. Sub types of diagnoses include clinical, laboratory, radiology. Advanced methods have been implemented to diagnose the infection in any part of the body.

Related Conferences

Infectious Conferences | infections Meetings | Emerging diseases 2018 | Infectious diseases conference

4th International conference on Flu & Emerging Infectious Diseases November 16-17, 2018 San Antonio, USA. 4th Annual Congress on Infectious Diseases September 17-18, 2018 San Diego, USA, 3rd Annual Congress on Rare Diseases and Orphan Drugs October 30-November 1, 2017 San Antonio, Texas, USA, 13th World Congress on Infection Prevention and Control Dec 14-15, 2017 Rome, Italy, 5th International congress on Infectious Diseases March 1-2, 2018 Berlin, Germany, 7th International Conference on Bacteriology and Infectious Diseases May 21-22, 2018 Osaka, Japan, 6th International Congress on Bacteriology and Infectious Diseases May 21-22, 2018 New York, USA, 4th World Congress on Rare Diseases and Orphan Drugs June 11-12, 2018 Dublin, Ireland, 4th International Conference on Influenza and Zoonotic Diseases July 2-3 2018 Vienna, Austria, 11th World Congress on Infectious Diseases and Therapy, July 23-25, 2018 Melbourne, Australia, 12th Annual Meet on Bacteriology & Applied Microbiology September 17-18, 2018 Singapore, 10thEuro-Global Conference on Infectious Diseases September 27-29, 2018 Rome, Italy

Track 05: Healthcare-associated Infection (HAIs)

Healthcare-associated Infection (HAIs) is infections that patients get while receiving treatment for medical or surgical conditions, and many HAIs are preventable. Modern healthcare employs many types of invasive devices and procedures to treat patients and to help them recover. Infections can be associated with procedures (like surgery) and also the devices used in medical procedures, like catheters or ventilators. HAIs are important causes of morbidity and mortality in the United States and are associated with a substantial increase in health care costs each year. At any one time in the United States, 1 out of every 25 hospitalized patients are affected by an HAI.

Related Conferences

Infectious Conferences | infections Meetings | Emerging diseases 2018 | Infectious diseases conference

3rd Annual Congress on Rare Diseases and Orphan Drugs , October 30-November 1, 2017 San Antonio, Texas, USA, 7th International Conference on Bacteriology and Infectious Diseases May 21-22, 2018 Osaka, Japan, 4th International Conference on Influenza and Zoonotic Diseases July 2-3 2018 Vienna, Austria, 9th International Conference on Emerging Infectious Diseases August 27-28, 2018 Zurich, Switzerland, 4th Annual Congress on Infectious Diseases September 17-18, 2018 San Diego, USA, 6th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs October 29-30, 2018 Valencia, Spain, 13th World Congress on Infection Prevention and Control Dec 14-15, 2017 Rome, Italy, 6th International Congress on Bacteriology and Infectious Diseases May 21-22, 2018 New York, USA, 11th World Congress on Infectious Diseases and Therapy, July 23-25, 2018 Melbourne, Australia, 12th Annual Meet on Bacteriology & Applied Microbiology September 17-18, 2018 Singapore, 10thEuro-Global Conference on Infectious Diseases September 27-29, 2018 Rome, Italy, 5th International congress on Infectious Diseases March 1-2, 2018 Berlin, Germany, 4th World Congress on Rare Diseases and Orphan Drugs June 11-12, 2018 Dublin, Ireland, 8th Asia Pacific STD and Infectious Diseases Congress, August 22-23, 2018 Tokyo, Japan

Track 06: HIV/AIDS from STDs & STIs

Human immunodeficiency virus(HIV) infection and acquired immune deficiency syndrome (AIDS) is a spectrum of conditions that can be caused by infection with the human immunodeficiency virus (HIV). Sexually transmitted diseases(STD)/ sexually transmitted infections(STI) are the infections which are transmitted through sexual contact with an infected individual and also transmitted during vaginal or other types of sexual intercourse including oral and anal sex. Basic STI services are in disarray as programme resources which can be determined by decisions relating to a single disease existence in many Countries. Major HIV epidemics emerged from different types of infections that can be spread rapidly under some conditions of poor STI control and further weakening of STI control may well undermine other HIV prevention efforts.

Related Conferences

Infectious Conferences | infections Meetings | Emerging diseases 2018 | Infectious diseases conference

5th International Conference on HIV/AIDS, STDs and STIs, November 13-14, 2017, Las Vegas, Nevada, USA, 9th World Congress and Expo on Immunology, Immunity, Inflammation and Immunotherapies November 2-3, 2017 Atlanta, Georgia, USA, 5th International Conference on HIV/AIDS, STDs and STIs, November 13-14, 2017, Las Vegas, Nevada, USA 9th Molecular Immunology & Immunogenetics Congress, March 08-09, 2018 London, UK, 11th Virology and Infectious Diseases Congress July 27-28, 2018 Vancouver, Canada, 9th World Congress and Expo on Immunology, Immunity, Inflammation and Immunotherapies November 02-03, 2017 Atlanta, Georgia, USA, World Immunology Congress, Dec 14-15, 2017 Dubai, UAE 3rd International Conference on Tumor & Cancer Immunology and Immunotherapy, September 17-18, 2018 San Diego, USA, Annual Congress On Immunology & Immunotechnology September 13-14, 2018 Zurich, Switzerland, 3rd International Conference on Tumor & Cancer Immunology and Immunotherapy, September 17-18, 2018 San Diego, USA, 10th Global Summit on Immunology and Cell biology May 28-29, 2018 Osaka, Japan, World Congress on Allergy and Immunotherapy, May 28-29, 2018 Osaka, Japan 2nd International Conference on Autoimmunity November 06-07, 2017 Frankfurt, Germany

Track 07: Infection by Zoonoses

Zoonosis / Animal infections are important hazard to human health since the emergence of human diseases is influenced by zoonotic pathogens. Infectious diseases affect livestock and also wild animals focusing on characterizing the conditions for the pathogen spread and maintenance in the present population. Scientist’s evaluation about the zoonotic diseases are that more than 8 out of every 12 known infectious diseases in humans are spread from faunas, and 4 out of every 5 new or emerging infectious diseases in people are spread from faunas. Yearly, calculated thousands of Americans gets sick from diseases spread between humans and faunas. By the cause of this, the national health agency works 24/7 to protect people from zoonotic diseases.

 Related Conferences

Infectious Conferences | infections Meetings | Emerging diseases 2018 | Infectious diseases conference

4th International Conference on Influenza and Zoonotic Diseases July 2-3 2018 Vienna, Austria, 9th  Emerging Infectious Diseases Conferences, 31st August-1st September 2018 ZurichSwitzerland; 4th  Rare Diseases Conferences, June 11-12, 2018 DublinIreland; 6th  Bacteriology  Conferences May 25-26, 2018 New York, USA; 5th  Infectious Conferences March 1-2, 2018 BerlinGermany, 6th  STDs, STIs & HIV/AIDS Conferences October 29-30, 2018 ValenciaSpain, 10th  Virology Conferences July 2-4, 2018 ViennaAustria, 8th  Microbiology ConferencesFebruary 22-23, 2018 ParisFrance. 11th Medical Microbiology Conferences July 19-21, 2018 RomeItaly. 2nd  STDs, STIs & HIV/AIDS Conferences, Montreal, Canada, May 18-19, 2018; 16th Influenza Conferences, Orlando, USA, March 28-29, 2018; 8th Inflammatory Diseases Conferences, Vienna, Austria, May 21-22, 2018; Bacteriology ConferencesParisFrance, June 18-19, 2018; 8th  Infectious Diseases ConferencesLondonUK, June 07-08, 2018; 10th Microbiology Conferences, June 14-16, 2018, LondonUK; 7th Microbiology Research Conferences, August 13-14, 2018, MadridSpainMicrobial Biotechnology Conferences, September 17-18, 2018 LisbonPortugal; 2nd Medical and Clinical Microbiology Conferences, July 16-17, 2018 MelbourneAustraliaMicrobial physiology Conferences July 16-18, 2018 LondonUK; 16th Microbiology Conferences, May 21-23, 2018, ViennaAustria

Track 08: Disinfection/Sterilization

An antimicrobic that deactivates just about reflects all recognized unhealthful pathogens however not essentially all microbic forms. They’ll not be effective against microorganism spores, and conjointly the entire destruction of all sorts of life by chemical or physical suggestions. This is often associate absolute not a relative term. Though physical ways square measure usually superior to chemical medical care sterilization, it's not sensible to autoclave or subject several things to high heat, particularly if the things are often broken through perpetual exposure to heat. However, multiple investigators have incontrovertible the effectiveness of those disinfectants against yeasts (e.g., Candida), viruses (e.g. poliovirus), and mycobacteria (e.g., eubacterium tuberculosis), vegetative bacterium (e.g., Salmonella, Escherichia coli, vancomycin-resistant Enterococci, Listeria, methicillin-resistant coccus aureus), at exposure times of 30–60 seconds

Related Conferences

Infectious Conferences | infections Meetings | Emerging diseases 2018 | Infectious diseases conference

4th International conference on Flu & Emerging Infectious Diseases November 16-17, 2018 San Antonio, USA. 4th Annual Congress on Infectious Diseases September 17-18, 2018 San Diego, USA, 3rd Annual Congress on Rare Diseases and Orphan Drugs October 30-November 1, 2017 San Antonio, Texas, USA, 13th World Congress on Infection Prevention and Control Dec 14-15, 2017 Rome, Italy, 5th International congress on Infectious Diseases March 1-2, 2018 Berlin, Germany, 7th International Conference on Bacteriology and Infectious Diseases May 21-22, 2018 Osaka, Japan, 6th International Congress on Bacteriology and Infectious Diseases May 21-22, 2018 New York, USA, 4th World Congress on Rare Diseases and Orphan Drugs June 11-12, 2018 Dublin, Ireland, 4th International Conference on Influenza and Zoonotic Diseases,  July 2-3 2018 Vienna, Austria, 11th World Congress on Infectious Diseases and Therapy, July 23-25, 2018 Melbourne, Australia, 12th Annual Meet on Bacteriology & Applied Microbiology September 17-18, 2018 Singapore, 10thEuro-Global Conference on Infectious Diseases September 27-29, 2018 Rome, Italy

Track 09: Infections from Plants

Plant diseases have caused for severe losses to humans in different ways. Starvation and uprooting of families resulted from the Irish famine caused by potato late blight. A valued resource was lost with the virtual elimination of the American chestnut by chestnut blight. And direct economic loss such as the estimated one billion dollars lost in one year to American corn growers from southern corn leaf blight. Many plant diseases cause less dramatic losses annually throughout the world but collectively constitute sizable losses to farmers and can reduce the aesthetic values of landscape plants and home gardens.

 Related Conferences

Infectious Conferences | infections Meetings | Emerging diseases 2018 | Infectious diseases conference

6th International Congress on Bacteriology and Infectious Diseases May 21-22, 2018 New York, USA, 4th Annual Congress on Infectious Diseases September 17-18, 2018 San Diego, USA, 3rd Annual Congress on Rare Diseases and Orphan Drugs October 30-November 1, 2017 San Antonio, Texas, USA, 3rd International Conference on Flu and Emerging Infectious Diseases November 06-07, 2017 Las Vegas, Nevada, USA, 13th World Congress on Infection Prevention and Control Dec 14-15, 2017 Rome, Italy, 5th International congress on Infectious Diseases March 1-2, 2018 Berlin, Germany, 7th International Conference on Bacteriology and Infectious Diseases May 21-22, 2018 Osaka, Japan, 6th International Congress on Bacteriology and Infectious Diseases May 21-22, 2018 New York, USA, 4th World Congress on Rare Diseases and Orphan Drugs June 11-12, 2018 Dublin, Ireland, 4th International Conference on Influenza and Zoonotic Diseases , July 2-3 2018 Vienna, Austria, 4th International conference on Flu & Emerging Infectious Diseases November 16-17, 2018 San Antonio, USA.

Track 10: Multidrug-Resistant Microorganisms

Multiresistance is antimicrobial resistance which can shown by a species of microorganism to multiple antimicrobial drugs. The types most threatening to public health are MDR bacteria that can resist multiple antibiotics and the other types include MDR viruses, fungi, and Recognizing different degrees of MDR, the terms extensively drug resistant (XDR) and pandrug-resistant (PDR) have been introduced. Various microorganisms have survived for thousands of years by their ability to adapt to antimicrobial agents. It is necessary to develop new antibiotics over time since the selection of resistant bacteria which cannot be prevented completely.

Related Conferences

Infectious Conferences | infections Meetings | Emerging diseases 2018 | Infectious diseases conference

9th International Conference on Emerging Infectious Diseases August 27-28, 2018 Zurich, Switzerland 3rd Annual Congress on Rare Diseases and Orphan Drugs October 30-November 1, 2017 San Antonio, Texas, USA, 4th Annual Congress on Infectious Diseases September 17-18, 2018 San Diego, USA,  5th International congress on Infectious Diseases March 1-2, 2018 Berlin, Germany, 6th International Congress on Bacteriology and Infectious Diseases May 21-22, 2018 New York, USA, 4th International Conference on Influenza and Zoonotic Diseases July 2-3 2018 Vienna, Austria, 8th Asia Pacific STD and Infectious Diseases Congress, August 22-23, 2018 Tokyo, Japan, 13th World Congress on Infection Prevention and Control  Dec 14-15, 2017 Rome, Italy, 4th World Congress on Rare Diseases and Orphan Drugs June 11-12, 2018 Dublin, Ireland, 11th World Congress on Infectious Diseases and Therapy, July 23-25, 2018 Melbourne, Australia, 10th Euro-Global Conference on Infectious Diseases September 27-29, 2018 Rome, Italy, 6th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs October 29-30, 2018 Valencia, Spain

Track 11: Infections During Pregnancy

Infections in a mother sometimes can be leads to birth defects in her unborn child. Maintaining proper hygiene and taking extra precautions can sometimes mean the difference between a healthy, happy baby and a life-threatening sickness. Use of irregular preventative treatment in pregnancy and using nets resulted in an estimated 94,000 new born deaths being averted between 2009 and 2012 in twenty five African countries. If these involvements had been applied to 80% of the at-risk population, it is estimated that 300,000 deaths could have been prevented.

Related Conferences

Infectious Conferences | infections Meetings | Emerging diseases 2018 | Infectious diseases conference

4th International conference on Flu & Emerging Infectious Diseases November 16-17, 2018 San Antonio, USA, 4th Annual Congress on Infectious Diseases September 17-18, 2018 San Diego, USA, 3rd Annual Congress on Rare Diseases and Orphan Drugs October 30-November 1, 2017 San Antonio, Texas, USA, 3rd International Conference on Flu and Emerging Infectious Diseases November 06-07, 2017 Las Vegas, Nevada, USA, 13th World Congress on Infection Prevention and Control Dec 14-15, 2017 Rome, Italy, 5th International congress on Infectious Diseases March 1-2, 2018 Berlin, Germany, 7th International Conference on Bacteriology and Infectious Diseases May 21-22, 2018 Osaka, Japan, 6th International Congress on Bacteriology and Infectious Diseases May 21-22, 2018 New York, USA, 4th World Congress on Rare Diseases and Orphan Drugs June 11-12, 2018 Dublin, Ireland, 4th International Conference on Influenza and Zoonotic Diseases July 2-3 2018 Vienna, Austria, 4th International conference on Flu & Emerging Infectious Diseases November 16-17, 2018 San Antonio, USA.

Track 12: Pediatric Infectious Diseases

Childhood infections / Pediatric infections are the infections which are caused in different age group children. Pediatric infections experts take care of the infections occurring in children and the treatment methods vary for children from adults. 11 million children deaths every year are attributable to six causes: neonatal infection, diarrhea, malaria, preterm delivery, pneumonia or lack of oxygen at birth. Some of the deaths occur from illnesses like malaria, measles or tetanus. Others result indirectly from marginalization, conflict and HIV/AIDS. Global burden of Pediatric mortality is increasing enormously every year.

Related Conferences

Infectious Conferences | infections Meetings | Emerging diseases 2018 | Infectious diseases conference

4th Annual Congress on Infectious Diseases September 17-18, 2018 San Diego, USA, 3rd Annual Congress on Rare Diseases and Orphan Drugs October 30-November 1, 2017 San Antonio, Texas, USA, 3rd International Conference on Flu and Emerging Infectious Diseases November 06-07, 2017 Las Vegas, Nevada, USA, 13th World Congress on Infection Prevention and Control Dec 14-15, 2017 Rome, Italy, 5th International congress on Infectious Diseases March 1-2, 2018 Berlin, Germany, 7th International Conference on Bacteriology and Infectious Diseases May 21-22, 2018 Osaka, Japan, 6th International Congress on Bacteriology and Infectious Diseases May 21-22, 2018 New York, USA, 4th World Congress on Rare Diseases and Orphan Drugs June 11-12, 2018 Dublin, Ireland, 4th International Conference  Influenza and Zoonotic Diseases July 2-3 2018 Vienna, Austria, 4th International conference on Flu & Emerging Infectious Diseases November 16-17, 2018 San Antonio, USA.

Track 13: Practices and Awareness

Public awareness refers to the important role that community knowledge and enthusiasm has in building manageable societies. Delivering knowledge to remote communities requires strategies for effective communication regarding infections treatment and control and maintenance of good hygienic conditions by creating healthy environment and infection free world. The growing aging population, with associated rise in the incidence of chronic diseases have also led to an increased demand of infection control products. However, factors such as stringent regulatory requirements and the need to comply with them may restrain the growth of infection control market to a certain extent.

Related Conferences

Infectious Conferences | infections Meetings | Emerging diseases 2018 | Infectious diseases conference

4th International Conference on Influenza and Zoonotic Diseases July 2-3 2018 Vienna, Austria, 9th  Emerging Infectious Diseases Conferences, 31st August-1st September 2018 ZurichSwitzerland; 4th  Rare Diseases Conferences, June 11-12, 2018 DublinIreland; 6th  Bacteriology  Conferences May 25-26, 2018 New York, USA; 5th  Infectious Conferences March 1-2, 2018 BerlinGermany, 6th  STDs, STIs & HIV/AIDS Conferences October 29-30, 2018 ValenciaSpain, 10th  Virology Conferences July 2-4, 2018 ViennaAustria, 8th  Microbiology ConferencesFebruary 22-23, 2018 ParisFrance. 11th Medical Microbiology Conferences July 19-21, 2018 RomeItaly. 2nd  STDs, STIs & HIV/AIDS Conferences, Montreal, Canada, May 18-19, 2018; 16th Influenza Conferences, Orlando, USA, March 28-29, 2018; 8th Inflammatory Diseases Conferences, Vienna, Austria, May 21-22, 2018; Bacteriology ConferencesParisFrance, June 18-19, 2018; 8th  Infectious Diseases ConferencesLondonUK, June 07-08, 2018; 10th Microbiology Conferences, June 14-16, 2018, LondonUK; 7th Microbiology Research Conferences, August 13-14, 2018, MadridSpainMicrobial Biotechnology Conferences, September 17-18, 2018 LisbonPortugal; 2nd Medical and Clinical Microbiology Conferences, July 16-17, 2018 MelbourneAustraliaMicrobial physiology Conferences July 16-18, 2018 LondonUK; 16th Microbiology Conferences, May 21-23, 2018, ViennaAustria

Track 14: Multi Pathogen Infections

Diagnostic Pathology requires with examination of body tissues and their examination, Microscopical study of disease determination, abnormal tissue development, histopathology of lesions and sometimes post-mortem. It does research on critical diagnosis in surgical pathology. Many diseases are associated with bacterial infections. A pathogen predisposes to diseases states but may not cause disease. It may cause disease only in combinations (toxins exposure).Any disease causing gene that reduces survival and reproduction will eliminate itself over a number of generations therefore genetic diseases are self-extinguishing. For example, genes that encode sickle cell anaemia are maintained and persist down generations, as these genes protect against malaria, which kills millions worldwide every year. About 70% deaths in US results from chronic diseases and the treatment accounting 75% of all US healthcare costs (amounting to $ 1.7 trillion in 2009).

Related Conferences

Infectious Conferences | infections Meetings | Emerging diseases 2018 | Infectious diseases conference

9th International Conference on Emerging Infectious Diseases August 27-28, 2018 Zurich, Switzerland 3rd Annual Congress on Rare Diseases and Orphan Drugs October 30-November 1, 2017 San Antonio, Texas, USA, 4th Annual Congress on Infectious Diseases September 17-18, 2018 San Diego, USA,  5th International congress on Infectious Diseases March 1-2, 2018 Berlin, Germany, 6th International Congress on Bacteriology and Infectious Diseases May 21-22, 2018 New York, USA, 4th International Conference on Influenza and Zoonotic Diseases July 2-3 2018 Vienna, Austria, 8th Asia Pacific STD and Infectious Diseases Congress, August 22-23, 2018 Tokyo, Japan, 13th World Congress on Infection Prevention and Control  Dec 14-15, 2017 Rome, Italy, 4th World Congress on Rare Diseases and Orphan Drugs June 11-12, 2018 Dublin, Ireland, 11th World Congress on Infectious Diseases and Therapy, July 23-25, 2018 Melbourne, Australia, 10th Euro-Global Conference on Infectious Diseases September 27-29, 2018 Rome, Italy, 6th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs October 29-30, 2018 Valencia, Spain

Track 15: Practical Guidelines

One of the prime effective ways in which we've got to protect ourselves from ill health is  personal hygiene. This suggests wash your hands especially, however additionally your body. It means that being careful to not cough or sneeze on others, cleansing things that you simply bit if you're unwell, golf stroke things like tissues into a bin, associate degree victimisation protection after you may be in danger of catching an infection. People should know about guidelines and recommendations related to infection prevention. HAIs are currently one of the top ten leading causes of death in the United States. Healthcare professionals have an important role in HAI prevention. Infection control measures are a set of standard recommendations that can be used to reduce the risk of transmission of infectious agents from body fluids that contain infectious agents.

Related Conferences

Infectious Conferences | infections Meetings | Emerging diseases 2018 | Infectious diseases conference

4th Annual Congress on Infectious Diseases September 17-18, 2018 San Diego, USA, 3rd Annual Congress on Rare Diseases and Orphan Drugs October 30-November 1, 2017 San Antonio, Texas, USA, 3rd International Conference on Flu and Emerging Infectious Diseases November 06-07, 2017 Las Vegas, Nevada, USA, 13th World Congress on Infection Prevention and Control Dec 14-15, 2017 Rome, Italy, 5th International congress on Infectious Diseases March 1-2, 2018 Berlin, Germany, 7th International Conference on Bacteriology and Infectious Diseases May 21-22, 2018 Osaka, Japan, 6th International Congress on Bacteriology and Infectious Diseases May 21-22, 2018 New York, USA, 4th World Congress on Rare Diseases and Orphan Drugs June 11-12, 2018 Dublin, Ireland, 4th International Conference on Influenza and Zoonotic Diseases July 2-3 2018 Vienna, Austria, 4th International conference on Flu & Emerging Infectious Diseases November 16-17, 2018 San Antonio, USA.

Track 16: Infection Control Business

Any discussion of the business case for infection control (IC) must start by acknowledging that the single most important reason for IC is to prevent morbidity and mortality associated with nosocomial infections. Each year, hundreds and thousands of Americans suffer the consequences of nosocomial infections which can be ranging from the inconvenience of taking extra medications to death. Beyond the human cost is the important economic burden that these infections place on society, including not only the obvious increase in health care resource use but also indirect costs associated with the loss of productivity of patients and their caregivers.

Related Conferences

Infectious Conferences | infections Meetings | Emerging diseases 2018 | Infectious diseases conference

6th International Congress on Bacteriology and Infectious Diseases May 21-22, 2018 New York, USA, 3rd Annual Congress on Rare Diseases and Orphan Drugs , October 30-November 1, 2017 San Antonio, Texas, USA, 7th International Conference on Bacteriology and Infectious Diseases May 21-22, 2018 Osaka, Japan, 4th International Conference on Influenza and Zoonotic Diseases July 2-3 2018 Vienna, Austria, 9th International Conference on Emerging Infectious Diseases August 27-28, 2018 Zurich, Switzerland, 4th Annual Congress on Infectious Diseases September 17-18, 2018 San Diego, USA, 6th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs October 29-30, 2018 Valencia, Spain, 13th World Congress on Infection Prevention and Control Dec 14-15, 2017 Rome, Italy, 11th World Congress on Infectious Diseases and Therapy, July 23-25, 2018 Melbourne, Australia, 12th Annual Meet on Bacteriology & Applied Microbiology September 17-18, 2018 Singapore, 10thEuro-Global Conference on Infectious Diseases September 27-29, 2018 Rome, Italy, 5th International congress on Infectious Diseases March 1-2, 2018 Berlin, Germany, 4th World Congress on Rare Diseases and Orphan Drugs June 11-12, 2018 Dublin, Ireland, 8th Asia Pacific STD and Infectious Diseases Congress, August 22-23, 2018 Tokyo, Japan

Other Conferences

International Conference on InfluenzaRome, Italy December 13 - 14, 2018, 20th  International Conference on Vaccines and Influenza, February 8 - 9, 2018 Bangkok, Thailand, The Microbiology Society Annual Conference, April 10-13, 2018, BirminghamUKClinical Virology Symposium May 6–9, 2018, West Palm Beach, Florida; 28th European Congress of Clinical Microbiology and Infectious Diseases, April 21 - 24 2018, MadridSpain; 68th Canadian Society of Microbiologists Annual Conference, June 18 - 21, 2018, Winnipeg, MB; 18th International Congress on Infectious Diseases, March 1-4, 2018, Buenos Aires, Argentina. 35th Annual Infectious Diseases Conference, February 3-4, 2017 Sacramento, CA, United States: 24th Conference on Retroviruses and Opportunistic Infections, February 13-16, 2017 Seattle, USA: 27th European Congress of Clinical Microbiology and Infectious Diseases, April 22-25, 2017 Vienna, Austria,

Related Societies:

USANational foundation of infectious disease Bethesda MarylandHIV Medicine Association

EuropeEuropean Society of Clinical Microbiology and Infectious diseases , British infection associationNASTAD

Asia PacificClinical infectious diseases society IndiaAustralasian Society for Infectious                Diseases, National   AIDS Control Organization

Market Analysis

Importance and Scope

The market is projected to reach USD 33.78 billion by 2021 and is growing at a CAGR of 8.3% during the forecast period which is from 2016 to 2021. Hospital acquired infections are also called as nosocomial infections and that are acquired in hospitals and other healthcare facilities. These infections can occur up to 48 hours after hospital admission or up to 3 days after discharge or up to 30 days after an operation or in a healthcare facility, when the patient was admitted for reasons other than infection.

The global hospital acquired infection control market is categorized which is on the basis of Pathogen Types (Viral, Bacterial, and Fungal), Treatment (Air, Water, Physical Surfaces, Skin Disinfectants, and Sterilization), Infection Type (Urinary Tract Infections, Blood Stream Infections, Surgical Site Infections, Hospital Acquired Pneumonia, Gastrointestinal Infections, and Tuberculosis), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

Conferenceseries LLC welcomes all the specialists and super specialists, research scholars, industrial professionals and student delegates from biomedical and healthcare sectors to be a part of the esteemed Infection Control-2018. It also catalyses for information exchange and networking between researchers and business entrepreneurs of diverse backgrounds for the advancement of Technology and Research in the field of Infection Control. As this will be the best amalgamation of academia and research involving every aspect of empirical and conceptual thinking in exploring new dimensions in this field. It is open to all types of research methodologies both from academia and industry.

WhyVancouver?
    Vancouver is a most populous city situated on the mainland of British Columbia, Canada and surrounded on 3 sides by water. Vancouver's moderate, oceanic climate makes it one of the warmest cities in Canada. With its scenic views, mild climate, and friendly people, Vancouver is known around the world as both a popular tourist attraction and one of the best places to live, Vancouver is named among top ten of the most liveable cities for 5 consecutive years. As Vancouver is covering a large portion it is third most populous metropolitan area of the country with a population of 603,500 as well as it is most densely populated city of North America after New York, Mexico City and San Francisco. The city of Vancouver is also classified as Beta global city. It is also named among top 5 worldwide cities for livability and quality of life.

                  Vancouver is also one of the most ethnically and linguistically diverse cities in Canada with 52 percent of the population speaking a first language other than English. Vancouver has hosted many international conferences and events, including the 2010 Winter Olympics and 2010 Winter Paralympics. The City continues to see an excellent return on investments made in the 2010 Winter Games, from sustainable community centers to public art, community involvement, and transportation infrastructure. 2011 was Vancouver’s 125th anniversary and year as Cultural Capital of Canada. Vancouver is very green and vibrant city having many symbols and most of the symbols represent our plant life, waterways, wildlife, and mountains.

The National Galleries of Vancouver: Stanley Park, SeaWorld, Grouse Mountain, Vancouver Aquarium, VanDusen Botanical Garden, Playland, Museum of Vancouver, Lynn Canyon Park, Seawall, Lighthouse Park, Sunset Beach.

Conference Highlights

·         Infection Treatment and Control

·         Emerging Infectious Diseases

·         Infection Novel Therapies

·         Treatment & Diagnosis

·         Healthcare-Associated Infection (HAIs)

·         HIV/AIDS from STDs & STIs

·         Infection by Zoonoses

·         Disinfection/Sterilization

·         Infections from Plants

·         Multidrug-Resistant Microorganisms

·         Infections During Pregnancy

·         Pediatric Infectious Diseases

·         Practices and Awareness

·         Multi Pathogen Infections

·         Practical Guidelines

·         Infection Control Business

Why to attend?

With members from around the world focused on learning about global trends on emerging infectious diseases and its advances in therapeutic and diagnostic market, this is your best opportunity to reach the largest assemblage of participants from the Infectious diseases community. This particular conference conduct presentations, distributes information, conducts meetings with current and potential scientists, make a splash with new drug developments, and receive name recognition at this 3 days event. World renowned speakers, the most recent therapeutic and diagnostic techniques, developments, and the Novel technologies and therapeutic measures for infectious diseases prevention and control are hallmarks of this conference.

Statistics of Researchers, Academicians and Industrial

·         International Federation of Infection Control (IFIC)

·         Association for Professionals in Infection Control and Epidemiology(APIC)

·         Infection Prevention Society (IPS)

·         American Journal of Infection Control(AJIC) 

·         Centers for Disease Control and Prevention(CDC)

·         Infectious Disease Society of America (IDSA)

·         Infectious Diseases Research Network (IDRN)

·         Australasian College for Infection Prevention and Control (ACIPC)

·         European Society for Clinical Microbiology and Infectious Diseases (ESCMID)

·         British Infection Association(BNA)

·         The Hospital Infection Society (HIS)

·         Infection Prevention Society (IPS)

·         World Health Organization (WHO) 

·         American Nurses Association(ANA)

·         Nigerian Infection Control Association (NICA) 

·         Infection Control Society of Southern Africa(ICSSA)

·         Washington State Hospital Association (WSHA)

Top Universities Worldwide

·         The University of British Columbia, Canada

·         American Sentinel University, USA

·         University of Toronto, Canada

·         University of South Florida,USA

·         Drexel University,USA

·         Griffith University,AUSTRALIA

·         Columbia University,USA

·         King's College London, University of London,UK

·         University of Dundee, Uk

·         University of Oxford,Uk

·         University of Cambridge,UK

·         Western University (Ontario), Canada

·         University of Otago, NEW ZEALAND

·         Imperial College London,UK

·         UCL (University College London),UK

·         Toi-Ohomai Institute of Technology, NEW ZEALAND

·         The University of Sydney, AUSTRALIA

·         Keele University, UK

Infection Control Therapeutic Market

The global market for infectious disease treatments was valued at $90.4 billion in 2009. This market is expected to increase at a compound annual growth rate (CAGR) of 8.8% to reach $138 billion in 2014. The largest market share belongs to antibiotic treatments for bacterial and fungal diseases at 53% of the total infectious disease treatment market.  Fungal disease treatments will experience a slightly higher compound annual growth rate (CAGR) of 6.2%, from $4.6 billion in 2009 to $6.2 billion in 2014. Viral disease treatments will have the fastest compound annual growth rate (CAGR) of 12.1%, increasing from nearly $45 billion in 2009 to $79 billion in 2014.

Infection Control Market worth 17.78 Billion USD by 2021

The infectious diseases therapeutic market in US is estimated to grow at a rate of 3.37% between 2014- 2019. As per the records, 25% of deaths are mainly due to infectious diseases globally. Current market trend shows that North America. America highest global market is expected in Asia then followed by the Europe in the global infectious diseases therapeutics market. 

The main reasons behind the highest global market of infectious diseases therapeutics market in the above countries is mainly due to large number of patients and due to increase in government funding. Market for infectious disease molecular diagnostics tests includes hospitals, blood banks, reference laboratories.

The report "Infection Control Market by Disinfection (Disinfectant, Disinfectors, Endoscope Reprocessors, Wipes, Face Masks) Sterilization (Steam Sterilization, Ethylene Oxide, VHP, E-beam, Contract Services) End User (Hospitals, Lifescience) - Global Forecast to 2021", analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa in the coming years

 

The rise in the incidences of different types of hospital acquired infections, innovative technologies implemented in devices that control infection, awareness regarding the use of personalized medicines, and cost-effective drugs to treat hospital acquired infections are some of the factors that are driving the growth of this market.

However, the lack of awareness regarding hospital acquired infection and increased usage of outpatient treatment are hampering the growth of this market.

 

Past Conference Report

Infection Control 2017

Infection Control 2017 Report

The 2nd International Conference on Infection Control and Prevention, hosted by Committee Infection Control 2017 was successfully held during September 25-26, 2017 in Chicago, USA. The conference highlighted the theme To safeguard public health. The conference was successful in gathering eminent speakers from various reputed organizations and their paramount talks enlightened the gathering.

The pragmatic meet organized by Committee Infection Control 2017 received a generous response from the Editorial Board Members of Committee Infection Control 2017 Journals as well as expertise from academia, talented researchers and young student community. Researchers and students who attended from different parts of the world made the conference one of the most successful and productive events in 2016 from Committee Infection Control 2017. The conference was marked by the presence of renowned Speakers, Young Researchers, Students and Business Delegates driving the two-day event into the path of success with thought-provoking keynote and plenary presentations.

The highlights of the meeting where the keynote lectures from

·         Stef Stienstra, Armed Forces of Netherlands, Netherlands

·         Paul Kadetz, Drew University, United States

·         Christine I Wooddell, Arrowhead Pharmaceuticals, USA

·         Lia Monica Junie, University of Medicine and Pharmacy, Romania

All the above mentioned Honorable Guests and Keynote speakers gave their energetic and fruitful contributions and special thanks to our Moderator Dr. Stef Stienstra, Armed Forces of Netherlands, Netherlands. For his remarkable contribution towards smooth functioning at Infection Control 2017. The meeting was carried out through various sessions, in which the discussions were held on the following major scientific tracks:

Infection Control 2017 with the sessions include Infection Treatment and Prevention Control | Pediatric Infections Prevention and Control | Resistance and Emerging Infectious Organisms | Infection Novel Therapies | Control of Zika/Malaria/Dengue Viral Infections | Hepatitis C | Surgical Infections Control | Control of HIV/AIDS from STDs & STIs | Antimicrobial Resistance| Microbial Pathogenesis | Infection Control and Hospital Epidemiology | Microbial Infections | Medical Microbiology | Immunity and Vaccination

To share your views and research, please click here to register for the Infection Control 2018 Conference.

The Committee Infection Control 2017 would like to convey a warm gratitude to all Honorable Guests and Keynote Speakers of Infection Control 2017 Conference.

Infection Control 2017 Conference witnessed an amalgamation of peerless speakers who enlightened the crowd with their knowledge and confabulated on various new-fangled topics related to the field of Infection Control. The event enlightened various areas of genomics in different fields with plenary lectures from the speakers of various universities and organizations like

·         Saungi McCalla, White Plains Hospital, USA

·         Yaa Boateng-Marfo, National University of Singapore, Singapore

·         Mohamed A Abouelkhair, University of Tennessee, USA

·         Hafid Soualhine, National Public Health Institute of Quebec, Canada

·         Shirley Gutkowski, Primal Air LLC, USA

·         Ibrahim Zeid, Hammoud Hospital University, Lebanon

·         Dhruv K. Mamtora, S. L. Raheja Hospital, India

We are obliged to various delegate experts, institutes and other eminent personalities who actively took part in the discussion and meetings. We sincerely thank the Organizing Committee Members for their gracious presence and continuous support towards the success of Infection Control-2017 Conference.

With the valuable feedback and generous response received from the participants of the event,

The committee Infection Control would like to announce the commencement of the 3rd International Conference on Infection Control and Prevention June 25-26, 2018 In Vancouver, Canada.

Contact us for more queries…!!!!

Infection Control 2018

Catherine Taylor

[email protected]

702-508-5200


Past Reports  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date June 25-26, 2018

For Sponsors & Exhibitors

[email protected]

Speaker Opportunity

Supported By

Journal of Infectious Diseases and Therapy Air and Water Borne Diseases Journal of Bacteriology and Parasitology Journal of Immunological Techniques in Infectious Diseases

All accepted abstracts will be published in respective Conferenceseries International Journals.

Abstracts will be provided with Digital Object Identifier by


Past Affiliations

Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos

Keytopics

  • Adenovirus Infections
  • Air-Borne Infections
  • Amoebiasis
  • Antenatal Screening
  • Anthrax
  • Antibiotic Use
  • Antimicrobial Resistance
  • Automated Surveillance
  • Avian Influenza
  • Bacillus Anthracis
  • Bacterial Infections
  • Blood-Borne Infections
  • Borreliosis
  • Botulism
  • Bovine Spongiform Encephalopathy - BSE
  • Burkholderia Pseudomallei
  • Campylobacteriosis
  • Catheter-Associated Urinary Tract Infection
  • Chagas Disease (American Trypanosomiasis)
  • Chikungunya Virus
  • Chlamydiosis
  • Cholera
  • Clostridium Difficile
  • Conjunctivitis
  • Control And Prevention Of Infections
  • Corynebacterium Infection
  • Cowpox
  • Coxsackievirus
  • Crimean-Congo Haemorrhagic Fever - CCHF
  • Cryptosporidiosis
  • Cyclosporiasis
  • Cytomegalovirus (Cme) Infection
  • Dengue Virus
  • Diphtheria
  • Diseases, Syndromes, Conditions
  • Ebola Virus
  • Echovirus
  • Emerging Or Re-Emerging Diseases
  • Encephalitis
  • Entamoeba Hystolitica
  • Enterohaemorrhagic E. Coli - Ehec
  • Epidemiology
  • Erythema Infectiosum (Fifth Disease)
  • Escherichia Coli
  • Evidence-Based Medicine
  • Flaviviridae
  • Food-Borne Infections
  • Fungal Infections
  • Gastrointestinal Disease
  • Giardia
  • Giardiasis
  • Gonorrhoea
  • Haemolytic Uraemic Syndrome
  • Haemophilus Influenzae
  • Haemophilus Influenzae Infection
  • Haemorrhagic Fever
  • Hantavirus Infections
  • Hepatitis
  • Human Papillomavirus Infection
  • Infection After Hysterectomy
  • Infection Control Nursing
  • Influenza
  • Influenza Virus
  • Invasive Pneumococcal Disease
  • Laboratory Surveillance
  • Legionellosis
  • Legionnaires' Disease
  • Listeriosis
  • Lyssaviruses
  • Medical Asepsis
  • Norovirus
  • Norovirus Infection
  • Parasitic Diseases
  • Phleboviruses
  • Poliovirus
  • Poxvirus
  • Protozoal Infections
  • Q Fever
  • Rabies
  • Respiratory Viruses
  • Rickettsia
  • Rift Valley Fever
  • Rotavirus Infection
  • Salmonella
  • Sexually Transmitted Infections
  • Standard Precautions
  • Staphylococcus Aureus
  • Toscana Virus
  • Transmission-Based Precautions
  • Tuberculosis
  • Tularaemia
  • Vaccine-Preventable Diseases
  • Vaccines And Immunisation
  • Variant Creutzfeld-Jakob Disease
  • Varicella Virus Infection (Chickenpox)
  • Vector-Borne Infections
  • Ventilator-Associated Pneumonia
  • Yellow Fever
  • Yersiniosis
  • Zoonoses